Ultrasound check to prevent lung problems after esophageal cancer surgery
Part of Cancer, Digestive system clinical trials.
This trial tests whether a special ultrasound check of the veins (called VExUS score) can help reduce lung problems after surgery for esophageal cancer. It aims to help older patients recover better and avoid complications.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 65 and 80 years old.
- You must be scheduled for a minimally invasive esophagectomy (surgery to remove part of the esophagus) at this hospital.
- Your body mass index (BMI) must be between 18 and 30 (generally not underweight or very overweight).
- You must be in generally good health (classified as ASA I to III) – this means you can have mild to severe but controlled medical conditions.
- You cannot have serious heart or lung problems, such as recent heart attack, severe heart failure, or high blood pressure in the lungs.
- You cannot have significant kidney or liver disease, or severe cognitive impairment (like memory loss).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests if using a special ultrasound exam (VExUS) to guide fluid management during lung surgery can help reduce complications like lung problems or kidney injury. It may help doctors give you just the right amount of fluids.
This study uses lung ultrasound before surgery to see if it can help predict breathing complications after major non-chest surgery. If you are having a long surgery under general anesthesia, this could help your care team better monitor and protect your lungs.
This study tests whether a structured symptom-reporting program helps people recover better after esophageal cancer surgery compared to usual care. If you are having surgery for esophageal cancer, this program might help manage your symptoms and improve your quality of life after the operation.
This study is looking for people newly diagnosed with esophageal cancer or cancer at the stomach-esophagus junction who are planning to have surgery. The goal is to see if certain noninvasive tests (like scans) can help predict how the disease will progress.
This trial tests a combination of three medicines (immunotherapy plus two chemotherapy drugs) given before surgery to shrink esophageal cancer. The goal is to make the tumor smaller and easier to remove completely, potentially improving the chance of a cure.
This trial tests if doing supervised exercise before esophageal cancer surgery (called prehabilitation) helps people recover better. You would follow a personalized exercise plan for at least 2 weeks before your scheduled surgery.
Hear when a new Esophageal Cancer (EsC) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.